These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3312176)

  • 1. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
    Chouinard G
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
    Feighner JP; Merideth CH; Claghorn JL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):47-51. PubMed ID: 6370974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
    J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two dosage regimens of fluoxetine in major depression.
    Rickels K; Smith WT; Glaudin V; Amsterdam JB; Weise C; Settle GP
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):38-41. PubMed ID: 3882680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
    Perry PJ; Garvey MJ; Kelly MW; Cook BL; Dunner FJ; Winokur G
    J Clin Psychiatry; 1989 Aug; 50(8):290-4. PubMed ID: 2668259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate in mild depression: a double-blind controlled trial.
    Mattes JA
    J Clin Psychiatry; 1985 Dec; 46(12):525-7. PubMed ID: 3905773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of morning versus evening fluoxetine administration.
    Usher RW; Beasley CM; Bosomworth JC
    J Clin Psychiatry; 1991 Mar; 52(3):134-6. PubMed ID: 2005078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind placebo-controlled multicenter evaluation of the efficacy and safety of nomifensine in depressed outpatients.
    Goldstein BJ; Brauzer B; Kentsmith D; Rosenthal S; Charalampous KD
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):52-5. PubMed ID: 6370975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.
    Reimherr FW; Chouinard G; Cohn CK; Cole JO; Itil TM; LaPierre YD; Masco HL; Mendels J
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():18-27. PubMed ID: 2258378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.
    Lineberry CG; Johnston JA; Raymond RN; Samara B; Feighner JP; Harto NE; Granacher RP; Weisler RH; Carman JS; Boyer WF
    J Clin Psychiatry; 1990 May; 51(5):194-9. PubMed ID: 2110559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression.
    de Jonghe F; Ravelli DP; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Mar; 24(2):62-7. PubMed ID: 1852793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.